Co-diagnostics, inc. sars-cov-2 test used in new community surveillance method in italy

Salt lake city, sept. 8, 2021 /prnewswire/ -- co-diagnostics, inc. (nasdaq: codx), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that its logix smart™ covid-19 test kit was used by italian researchers to confirm the presence of sars-cov-2, including mutated strains of the virus, in a community surveillance method of testing single-use waste, with the peer-reviewed results published in the journal science of the total environment.
CODX Ratings Summary
CODX Quant Ranking